|
2025-03-05 |
2025-03-04 |
V
Vente
|
Burkly Linda
EVP, CHIEF SCIENTIFIC OFFICER
Dirigeant
|
2 891
-4.0%
1,71
4 946 USD
|
2 891
-4.0%
|
1,71
|
4 946 USD
|
|
|
2025-03-05 |
2025-03-04 |
V
Vente
|
O'Neill Gilmore Neil
CEO
Administrateur exécutif
|
16 632
-5.3%
1,71
28 452 USD
|
16 632
-5.3%
|
1,71
|
28 452 USD
|
|
|
2025-03-05 |
2025-03-04 |
V
Vente
|
Lucera Erick
EVP, CHIEF FINANCIAL OFFICER
Dirigeant
|
4 109
-3.5%
1,71
7 030 USD
|
4 109
-3.5%
|
1,71
|
7 030 USD
|
|
|
2024-12-05 |
2024-12-03 |
V
Vente
|
O'Neill Gilmore Neil
CEO
Administrateur exécutif
|
1 618
-0.5%
2,08
3 361 USD
|
1 618
-0.5%
|
2,08
|
3 361 USD
|
|
|
2024-12-05 |
2024-12-03 |
V
Vente
|
Mei Baisong
EVP, CHIEF MEDICAL OFFICER
Dirigeant
|
541
-0.4%
2,08
1 124 USD
|
541
-0.4%
|
2,08
|
1 124 USD
|
|
|
2024-09-06 |
2024-09-04 |
V
Vente
|
Mei Baisong
EVP, CHIEF MEDICAL OFFICER
Dirigeant
|
518
-0.4%
3,42
1 774 USD
|
518
-0.4%
|
3,42
|
1 774 USD
|
|
|
2024-09-06 |
2024-09-04 |
V
Vente
|
O'Neill Gilmore Neil
CEO
Administrateur exécutif
|
1 555
-0.5%
3,42
5 325 USD
|
1 555
-0.5%
|
3,42
|
5 325 USD
|
|
|
2024-07-26 |
2024-07-25 |
V
Vente
|
Burkly Linda
EVP, CHIEF SCIENTIFIC OFFICER
Dirigeant
|
11 886
-14.0%
5,42
64 370 USD
|
11 886
-14.0%
|
5,42
|
64 370 USD
|
|
|
2024-07-22 |
2024-07-19 |
V
Vente
|
Mei Baisong
EVP, CHIEF MEDICAL OFFICER
Dirigeant
|
6 619
-4.7%
5,21
34 456 USD
|
6 619
-4.7%
|
5,21
|
34 456 USD
|
|
|
2024-06-06 |
2024-06-04 |
V
Vente
|
Mei Baisong
EVP, CHIEF MEDICAL OFFICER
Dirigeant
|
511
-0.4%
5,50
2 808 USD
|
511
-0.4%
|
5,50
|
2 808 USD
|
|
|
2024-06-06 |
2024-06-04 |
V
Vente
|
O'Neill Gilmore Neil
CEO
Administrateur exécutif
|
12 191
-3.7%
5,50
66 997 USD
|
12 191
-3.7%
|
5,50
|
66 997 USD
|
|
|
2024-05-22 |
2024-05-20 |
V
Vente
|
Lucera Erick
EVP, CHIEF FINANCIAL OFFICER
Dirigeant
|
22 337
-16.1%
5,61
125 404 USD
|
22 337
-16.1%
|
5,61
|
125 404 USD
|
|
|
2024-05-14 |
2024-05-13 |
A
Achat
|
Hopfield Jessica
Administrateur non-exécutif
|
45 000
+198.2%
5,64
253 868 USD
|
45 000
+198.2%
|
5,64
|
253 868 USD
|
|
|
2024-05-14 |
2024-05-13 |
A
Achat
|
Hopfield Jessica
Administrateur non-exécutif
|
45 000
+198.2%
5,64
253 868 USD
|
45 000
+198.2%
|
5,64
|
253 868 USD
|
|
|
2024-03-05 |
2024-03-05 |
V
Vente
|
O'Neill Gilmore Neil
CEO
Administrateur exécutif
|
77 824
-19.2%
9,42
732 884 USD
|
77 824
-19.2%
|
9,42
|
732 884 USD
|
|
|
2024-03-05 |
2024-03-04 |
V
Vente
|
Mei Baisong
SVP, CHIEF MEDICAL OFFICER
Dirigeant
|
20 327
-12.6%
9,42
191 425 USD
|
20 327
-12.6%
|
9,42
|
191 425 USD
|
|
|
2023-12-07 |
2023-12-05 |
V
Vente
|
Eaton Bruce
EVP, CBO AND CTO
Dirigeant
|
103
-0.1%
10,90
1 122 USD
|
103
-0.1%
|
10,90
|
1 122 USD
|
|
|
2023-11-16 |
2023-11-14 |
V
Vente
|
Eaton Bruce
EVP, CBO AND CTO
Dirigeant
|
695
-0.9%
8,21
5 706 USD
|
695
-0.9%
|
8,21
|
5 706 USD
|
|
|
2023-11-09 |
2023-11-07 |
V
Vente
|
Eaton Bruce
EVP, CBO AND CTO
Dirigeant
|
139
-0.2%
8,40
1 168 USD
|
139
-0.2%
|
8,40
|
1 168 USD
|
|
|
2023-09-07 |
2023-09-06 |
V
Vente
|
Eaton Bruce
EVP, CBO AND CTO
Dirigeant
|
103
-0.1%
8,82
908 USD
|
103
-0.1%
|
8,82
|
908 USD
|
|
|
2023-08-15 |
2023-08-11 |
V
Vente
|
Eaton Bruce
EVP, CBO AND CTO
Dirigeant
|
702
-0.9%
8,59
6 033 USD
|
702
-0.9%
|
8,59
|
6 033 USD
|
|
|
2023-08-10 |
2023-08-08 |
V
Vente
|
Eaton Bruce
EVP, CBO AND CTO
Dirigeant
|
141
-0.2%
8,39
1 183 USD
|
141
-0.2%
|
8,39
|
1 183 USD
|
|
|
2023-07-21 |
2023-07-19 |
V
Vente
|
Mei Baisong
SVP, CHIEF MEDICAL OFFICER
Dirigeant
|
4 317
-5.7%
8,80
37 990 USD
|
4 317
-5.7%
|
8,80
|
37 990 USD
|
|
|
2023-06-07 |
2023-06-05 |
V
Vente
|
Eaton Bruce
EVP, CBO AND CTO
Dirigeant
|
105
-0.1%
9,50
998 USD
|
105
-0.1%
|
9,50
|
998 USD
|
|
|
2023-06-07 |
2023-06-05 |
V
Vente
|
O'Neill Gilmore Neil
CEO
Administrateur exécutif
|
6 486
-4.7%
9,50
61 638 USD
|
6 486
-4.7%
|
9,50
|
61 638 USD
|
|
|
2023-05-15 |
2023-05-11 |
V
Vente
|
ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER
Dirigeant
|
949
-0.9%
9,87
9 369 USD
|
949
-0.9%
|
9,87
|
9 369 USD
|
|
|
2023-05-15 |
2023-05-11 |
V
Vente
|
Eaton Bruce
EVP, CBO AND CTO
Dirigeant
|
668
-0.9%
9,87
6 594 USD
|
668
-0.9%
|
9,87
|
6 594 USD
|
|
|
2023-05-11 |
2023-05-09 |
V
Vente
|
Eaton Bruce
EVP, CBO AND CTO
Dirigeant
|
135
-0.2%
9,51
1 284 USD
|
135
-0.2%
|
9,51
|
1 284 USD
|
|
|
2023-03-06 |
2023-03-03 |
V
Vente
|
ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER
Dirigeant
|
184
-0.2%
8,89
1 636 USD
|
184
-0.2%
|
8,89
|
1 636 USD
|
|
|
2023-03-06 |
2023-03-03 |
V
Vente
|
Eaton Bruce
EVP, CBO AND CTO
Dirigeant
|
101
-0.1%
8,89
898 USD
|
101
-0.1%
|
8,89
|
898 USD
|
|
|
2023-02-15 |
2023-02-13 |
V
Vente
|
Eaton Bruce
EVP, CBO AND CTO
Dirigeant
|
3 307
-5.1%
9,67
31 963 USD
|
3 307
-5.1%
|
9,67
|
31 963 USD
|
|
|
2023-02-15 |
2023-02-13 |
V
Vente
|
ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER
Dirigeant
|
4 287
-5.3%
9,67
41 435 USD
|
4 287
-5.3%
|
9,67
|
41 435 USD
|
|
|
2023-02-15 |
2023-02-13 |
V
Vente
|
Shearman Mark S
EVP, CHIEF SCIENTIFIC OFFICER
Dirigeant
|
2 790
-4.1%
9,67
26 966 USD
|
2 790
-4.1%
|
9,67
|
26 966 USD
|
|
|
2023-02-09 |
2023-02-07 |
V
Vente
|
Eaton Bruce
EVP, CBO AND CTO
Dirigeant
|
346
-0.5%
11,10
3 841 USD
|
346
-0.5%
|
11,10
|
3 841 USD
|
|
|
2023-01-12 |
2023-01-10 |
V
Vente
|
ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER
Dirigeant
|
1 752
-2.1%
8,16
14 296 USD
|
1 752
-2.1%
|
8,16
|
14 296 USD
|
|
|
2022-12-06 |
2022-12-05 |
V
Vente
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Dirigeant
|
102
-0.2%
10,23
1 043 USD
|
102
-0.2%
|
10,23
|
1 043 USD
|
|
|
2022-12-06 |
2022-12-05 |
V
Vente
|
ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER
Dirigeant
|
193
-0.2%
10,23
1 974 USD
|
193
-0.2%
|
10,23
|
1 974 USD
|
|
|
2022-11-09 |
2022-11-08 |
V
Vente
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Dirigeant
|
289
-0.4%
11,02
3 185 USD
|
289
-0.4%
|
11,02
|
3 185 USD
|
|
|
2022-09-08 |
2022-09-06 |
V
Vente
|
ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER
Dirigeant
|
192
-0.2%
15,01
2 882 USD
|
192
-0.2%
|
15,01
|
2 882 USD
|
|
|
2022-09-08 |
2022-09-06 |
V
Vente
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Dirigeant
|
101
-0.2%
15,01
1 516 USD
|
101
-0.2%
|
15,01
|
1 516 USD
|
|
|
2022-08-10 |
2022-08-09 |
V
Vente
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Dirigeant
|
293
-0.4%
18,60
5 449 USD
|
293
-0.4%
|
18,60
|
5 449 USD
|
|
|
2022-06-16 |
2022-06-15 |
V
Vente
|
Shearman Mark S
EVP, CHIEF SCIENTIFIC OFFICER
Dirigeant
|
5 145
-7.0%
10,06
51 745 USD
|
5 145
-7.0%
|
10,06
|
51 745 USD
|
|
|
2022-06-06 |
2022-06-03 |
V
Vente
|
ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER
Dirigeant
|
1 527
-1.8%
11,54
17 617 USD
|
1 527
-1.8%
|
11,54
|
17 617 USD
|
|
|
2022-06-06 |
2022-06-03 |
V
Vente
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Dirigeant
|
1 123
-1.7%
11,54
12 956 USD
|
1 123
-1.7%
|
11,54
|
12 956 USD
|
|
|
2022-05-11 |
2022-05-09 |
V
Vente
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Dirigeant
|
297
-0.4%
13,11
3 895 USD
|
297
-0.4%
|
13,11
|
3 895 USD
|
|
|
2022-04-04 |
2022-04-01 |
V
Vente
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Dirigeant
|
1 258
-1.8%
19,64
24 707 USD
|
1 258
-1.8%
|
19,64
|
24 707 USD
|
|
|
2022-03-07 |
2022-03-03 |
V
Vente
|
ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER
Dirigeant
|
767
-0.9%
17,33
13 290 USD
|
767
-0.9%
|
17,33
|
13 290 USD
|
|
|
2022-03-07 |
2022-03-03 |
V
Vente
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Dirigeant
|
403
-0.6%
17,33
6 983 USD
|
403
-0.6%
|
17,33
|
6 983 USD
|
|
|
2022-02-10 |
2022-02-08 |
V
Vente
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Dirigeant
|
302
-1.0%
17,63
5 323 USD
|
302
-1.0%
|
17,63
|
5 323 USD
|
|
|
2022-01-13 |
2022-01-11 |
V
Vente
|
ROBERTSON MICHELLE
Chief Financial Officer
Dirigeant
|
1 744
-5.3%
25,70
44 821 USD
|
1 744
-5.3%
|
25,70
|
44 821 USD
|
|
|
2022-01-04 |
2022-01-03 |
V
Vente
|
MULLEN JAMES C
CEO
Administrateur exécutif
|
18 252
-19.4%
26,95
491 979 USD
|
18 252
-19.4%
|
26,95
|
491 979 USD
|
|
|
2021-11-15 |
2021-11-12 |
V
Vente
|
Michaels Lisa Anne
EVP/Chief Medical Officer
Dirigeant
|
1 568
-7.8%
38,33
60 101 USD
|
1 568
-7.8%
|
38,33
|
60 101 USD
|
|
|
2021-11-10 |
2021-11-09 |
V
Vente
|
Eaton Bruce
EVP, Chief Business Officer
Dirigeant
|
287
-1.0%
40,61
11 655 USD
|
287
-1.0%
|
40,61
|
11 655 USD
|
|
|
2021-10-20 |
2021-10-18 |
V
Vente
|
MULLEN JAMES C
CEO
Administrateur exécutif
|
13 805
-19.3%
38,03
525 033 USD
|
13 805
-19.3%
|
38,03
|
525 033 USD
|
|
|
2022-04-04 |
2021-08-09 |
V
Vente
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Dirigeant
|
287
-0.4%
57,17
16 408 USD
|
287
-0.4%
|
57,17
|
16 408 USD
|
|
|
2021-03-05 |
2021-03-03 |
A
Achat
|
Hopfield Jessica
Administrateur non-exécutif
|
5 800
+34.3%
45,51
263 970 USD
|
5 800
+34.3%
|
45,51
|
263 970 USD
|
|
|
2021-03-04 |
2021-03-02 |
A
Achat
|
MULLEN JAMES C
CEO
Administrateur exécutif
|
25 000
+250.0%
46,27
1 156 800 USD
|
25 000
+250.0%
|
46,27
|
1 156 800 USD
|
|
|
2021-02-10 |
2021-02-09 |
V
Vente
|
Collins Cynthia
CEO
Dirigeant
|
1 262
-2.8%
66,65
84 112 USD
|
1 262
-2.8%
|
66,65
|
84 112 USD
|
|
|
2021-01-13 |
2021-01-12 |
V
Vente
|
ROBERTSON MICHELLE
Chief Financial Officer
Dirigeant
|
1 568
-7.8%
78,27
122 727 USD
|
1 568
-7.8%
|
78,27
|
122 727 USD
|
|
|
2020-12-17 |
2020-12-15 |
VP
Vente planifiée
|
Albright Charles
EVP/Chief Scientific Officer
Dirigeant
|
200
-0.8%
64,39
12 878 USD
|
200
-0.8%
|
64,39
|
12 878 USD
|
|
|
2020-12-17 |
2020-12-15 |
VP
Vente planifiée
|
Albright Charles
EVP/Chief Scientific Officer
Dirigeant
|
4 024
-13.8%
63,84
256 892 USD
|
4 024
-13.8%
|
63,84
|
256 892 USD
|
|
|
2020-12-17 |
2020-12-15 |
VP
Vente planifiée
|
Albright Charles
EVP/Chief Scientific Officer
Dirigeant
|
5 776
-16.5%
62,74
362 386 USD
|
5 776
-16.5%
|
62,74
|
362 386 USD
|
|
|
2020-12-11 |
2020-12-09 |
VP
Vente planifiée
|
Albright Charles
EVP/Chief Scientific Officer
Dirigeant
|
10 000
-28.6%
45,00
450 000 USD
|
10 000
-28.6%
|
45,00
|
450 000 USD
|
|
|
2020-12-08 |
2020-12-07 |
VP
Vente planifiée
|
Albright Charles
EVP/Chief Scientific Officer
Dirigeant
|
20 000
-44.5%
40,02
800 400 USD
|
20 000
-44.5%
|
40,02
|
800 400 USD
|
|
|
2020-11-10 |
2020-11-09 |
V
Vente
|
Albright Charles
EVP/Chief Scientific Officer
Dirigeant
|
228
-0.9%
31,21
7 116 USD
|
228
-0.9%
|
31,21
|
7 116 USD
|
|
|
2020-10-16 |
2020-10-15 |
VP
Vente planifiée
|
Albright Charles
EVP/Chief Scientific Officer
Dirigeant
|
3 000
-10.7%
31,39
94 170 USD
|
3 000
-10.7%
|
31,39
|
94 170 USD
|
|
|
2020-08-21 |
2020-08-20 |
V
Vente
|
Collins Cynthia
CEO
Administrateur exécutif
|
1 976
-4.2%
36,66
72 440 USD
|
1 976
-4.2%
|
36,66
|
72 440 USD
|
|
|
2020-08-19 |
2020-08-17 |
VP
Vente planifiée
|
Albright Charles
EVP/Chief Scientific Officer
Dirigeant
|
10 000
-26.2%
35,29
352 900 USD
|
10 000
-26.2%
|
35,29
|
352 900 USD
|
|
|
2020-08-10 |
2020-08-07 |
V
Vente
|
Albright Charles
EVP/Chief Scientific Officer
Dirigeant
|
238
-0.8%
34,99
8 328 USD
|
238
-0.8%
|
34,99
|
8 328 USD
|
|
|
2020-08-10 |
2020-08-06 |
VP
Vente planifiée
|
Albright Charles
EVP/Chief Scientific Officer
Dirigeant
|
10 000
-26.1%
37,47
374 700 USD
|
10 000
-26.1%
|
37,47
|
374 700 USD
|
|
|
2020-07-17 |
2020-07-15 |
VP
Vente planifiée
|
Albright Charles
EVP/Chief Scientific Officer
Dirigeant
|
3 000
-9.6%
32,22
96 660 USD
|
3 000
-9.6%
|
32,22
|
96 660 USD
|
|
|
2020-05-08 |
2020-05-06 |
V
Vente
|
Albright Charles
EVP/Chief Scientific Officer
Dirigeant
|
151
-0.5%
25,28
3 817 USD
|
151
-0.5%
|
25,28
|
3 817 USD
|
|
|
2020-02-10 |
2020-02-07 |
V
Vente
|
Albright Charles
Chief Scientific Officer
Dirigeant
|
622
-1.9%
26,95
16 763 USD
|
622
-1.9%
|
26,95
|
16 763 USD
|
|
|
2020-02-04 |
2020-02-03 |
V
Vente
|
Albright Charles
Chief Scientific Officer
|
5 549
-21.3%
26,54
147 288 USD
|
5 549
-21.3%
|
26,54
|
147 288 USD
|
|
|
2019-08-21 |
2019-08-19 |
V
Vente
|
Collins Cynthia
CEO
Administrateur exécutif
|
5 193
-31.3%
25,83
134 135 USD
|
5 193
-31.3%
|
25,83
|
134 135 USD
|
|
